• settings
  • CC
  • 360p
  • 480p
  • 720p
  • 1080p
3,643 VIEWS | 0 LIKES

Human embryonic stem cell-derived cardiomyocytes for drug safety testing

from GE Healthcare Life Sciences

View compelling data that shows how human embryonic stem cell derived Cytiva™ cardiomyocytes can be a powerful approach to assessing cardiac drug liabilities. Nick Thomas, Principal Scientist at GE Healthcare Life Sciences describes how hESC derived Cytiva cardiomyocytes: •are a valid model of cardiomyocytes from the human heart •are compatible with assays routinely used for testing cardiotoxicity •together with high-content assays and analysis, can indicate the mechanism of toxicity of drug compounds.

about 7 years ago

Recommended Videos
Latest Videos

We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy